Insperity (NSP) Q4 2025 Earnings
Reported Feb 10, 2026 at 4:46 PM ET · SEC Source
Q4 25 EPS
$-0.60
MISS 28.89%
Est. $-0.47
Q4 25 Revenue
$1.67B
MISS 0.62%
Est. $1.68B
vs S&P Since Q4 25
+26.4%
BEATING MARKET
NSP +34.2% vs S&P +7.8%
Full Year 2025 Results
FY 25 EPS
$1.03
FY 25 Revenue
$6.81B
Market Reaction
Did NSP Beat Earnings? Q4 2025 Results
Insperity closed out fiscal 2025 on a sour note, posting a steeper-than-expected Q4 loss as relentless benefits cost pressures overwhelmed modest top-line growth. The professional employer organization reported adjusted EPS of -$0.60 for the quarter,… Read more Insperity closed out fiscal 2025 on a sour note, posting a steeper-than-expected Q4 loss as relentless benefits cost pressures overwhelmed modest top-line growth. The professional employer organization reported adjusted EPS of -$0.60 for the quarter, missing the consensus estimate of -$0.47 by 28.89%, while revenue of $1.67 billion edged 3.4% higher year over year but fell just short of the $1.68 billion Wall Street had anticipated. The core culprit was a sharp deterioration in gross profit, which tumbled 21% to $172.00 million as elevated inpatient, outpatient, and pharmacy cost trends, compounded by large-claim frequency, erased pricing gains from a 2% increase in revenue per worksite employee. Shares slipped roughly 7.6% following the report, reflecting investor frustration with the sustained benefits drag. Management is betting that restructured UnitedHealthcare contracts, tighter client selection, and new growth initiatives will drive a meaningful rebound, guiding full-year 2026 adjusted EPS of $1.69 to $2.72, representing a recovery of 64% to 164% above depressed 2025 levels.
Key Takeaways
- • Elevated benefits costs driven by inpatient, outpatient, and pharmacy trends and large claim frequency
- • 2% increase in revenue per WSEE per month from higher pricing
- • 1% growth in average paid WSEEs to 312,377 in Q4
- • 6% decrease in operating expenses to $218 million in Q4
- • Reduced Workday strategic partnership costs ($10M in Q4 2025 vs $19M in Q4 2024)
NSP YoY Financials
Q4 2025 vs Q4 2024, source: SEC Filings
“We accomplished the key objective of our year-end transition with a step up in gross profit margin, which we believe positions the company for a significant recovery in profitability this year.”
— Paul J. Sarvadi, Q4 2025 Earnings Press Release
NSP Earnings Trends
NSP vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
NSP EPS Trend
Earnings per share: estimate vs actual
NSP Revenue Trend
Quarterly revenue: estimate vs actual
NSP Quarterly Results
4 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $1.23 | $1.31 | +6.18% | $1.90B | +0.09% |
| Q4 25 MISS FY | $-0.47 | $-0.60 | -28.89% | $1.67B | -0.62% |
| FY Full Year | — | $1.03 | — | $6.81B | — |
| Q3 25 MISS | $0.22 | $-0.20 | -190.09% | $1.62B | -0.55% |
| Q2 25 MISS | $0.41 | $0.26 | -36.27% | $1.66B | -0.25% |